We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
SERPIND1
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • SERPIND1
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

SERPIND1 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 427.5
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 487.1
Number of samples 362
Samples
Sample Description pTPM
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 2175.4
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 1737.1
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 1485.0
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 1410.3
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 1388.0
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 1242.0
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 1219.9
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 1174.7
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 1163.5
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 1159.2
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 1154.3
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 1145.2
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 1143.3
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 1118.7
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 1076.9
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 1075.0
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 1071.3
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 1070.5
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 1066.3
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 1053.6
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 1045.4
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 1041.8
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 1041.0
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 1008.9
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 990.8
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 974.4
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 951.5
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 947.4
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 944.2
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 941.8
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 936.7
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 929.4
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 920.9
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 914.3
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 898.0
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 896.0
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 893.1
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 884.3
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 882.7
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 880.4
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 876.6
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 876.6
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 876.2
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 869.9
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 865.2
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 861.9
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 857.4
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 829.2
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 827.6
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 820.9
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 813.5
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 813.0
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 794.2
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 777.8
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 776.3
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 773.9
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 772.8
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 753.1
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 750.1
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 746.5
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 744.9
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 741.3
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 735.0
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 734.9
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 734.8
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 734.8
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 731.4
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 731.2
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 729.7
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 729.0
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 726.9
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 719.2
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 703.4
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 691.5
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 682.6
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 679.5
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 672.1
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 670.6
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 667.3
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 666.7
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 666.0
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 665.3
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 664.3
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 661.4
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 660.0
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 657.3
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 656.2
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 654.0
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 653.1
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 650.6
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 646.7
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 644.6
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 644.4
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 637.9
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 637.1
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 635.7
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 635.4
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 634.8
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 634.8
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 626.7
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 626.3
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 619.0
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 617.6
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 614.7
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 613.0
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 606.9
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 606.3
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 586.2
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 583.5
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 578.5
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 576.1
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 575.2
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 575.1
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 574.4
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 574.4
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 572.8
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 570.6
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 569.0
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 568.6
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 567.7
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 558.5
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 558.3
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 558.2
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 553.8
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 545.2
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 544.2
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 543.1
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 542.4
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 541.6
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 540.6
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 539.8
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 539.5
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 535.9
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 535.3
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 532.8
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 530.5
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 528.1
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 528.0
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 519.5
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 517.1
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 516.1
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 513.5
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 512.7
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 512.6
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 511.7
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 511.4
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 509.1
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 508.8
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 501.0
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 500.8
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 499.5
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 497.5
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 496.5
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 495.4
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 490.4
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 487.6
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 486.9
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 485.9
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 484.8
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 481.5
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 481.3
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 477.5
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 477.0
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 476.1
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 474.3
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 468.2
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 467.1
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 462.2
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 460.4
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 457.0
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 454.8
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 451.2
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 449.4
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 448.9
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 445.8
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 445.3
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 443.1
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 442.5
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 441.9
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 441.1
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 438.8
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 435.8
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 435.8
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 434.0
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 433.0
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 430.9
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 428.2
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 427.8
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 427.2
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 425.4
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 423.2
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 422.1
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 420.8
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 420.5
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 416.8
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 415.6
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 413.4
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 411.0
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 409.3
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 409.0
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 408.3
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 404.7
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 400.3
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 396.7
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 396.5
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 396.4
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 396.1
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 392.1
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 387.1
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 385.4
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 385.2
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 383.6
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 382.7
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 381.1
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 381.1
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 380.5
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 380.3
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 380.0
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 373.7
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 373.0
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 364.8
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 363.6
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 362.1
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 362.0
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 361.8
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 361.6
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 360.7
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 357.4
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 349.7
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 346.9
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 345.0
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 344.9
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 342.5
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 337.9
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 337.6
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 337.3
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 336.3
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 335.9
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 335.5
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 334.4
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 334.3
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 333.4
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 333.2
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 331.1
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 330.6
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 327.0
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 325.9
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 325.6
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 324.8
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 323.9
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 323.1
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 321.5
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 318.3
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 317.9
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 316.5
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 312.3
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 310.8
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 309.4
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 308.4
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 307.8
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 307.6
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 307.3
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 301.5
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 301.3
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 297.0
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 296.5
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 294.8
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 294.5
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 292.0
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 290.5
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 287.6
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 287.5
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 282.8
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 280.8
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 279.5
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 278.2
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 277.7
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 277.6
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 270.8
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 270.3
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 269.1
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 267.6
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 264.7
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 262.7
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 260.7
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 257.9
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 256.1
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 251.3
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 246.7
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 246.0
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 239.0
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 239.0
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 238.4
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 238.0
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 237.2
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 235.4
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 231.2
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 231.1
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 230.7
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 229.1
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 228.4
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 227.9
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 226.9
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 225.9
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 223.0
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 221.7
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 209.7
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 209.4
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 208.8
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 208.5
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 204.9
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 200.7
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 198.5
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 195.7
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 184.3
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 182.1
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 180.6
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 173.7
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 172.1
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 169.4
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 168.9
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 166.1
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 160.6
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 153.3
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 151.6
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 148.1
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 146.3
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 138.2
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 132.6
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 123.6
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 122.6
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 103.8
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 92.9
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 91.9
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 90.9
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 87.9
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 83.8
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 79.7
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 72.1
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 61.2
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 36.6
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 35.3
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 33.2
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 32.4
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 23.1
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 21.5
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 16.2
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 16.0
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 14.6
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 7.8
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 5.5
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 5.1
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 1.8
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 1.4
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 1.2
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 1.0
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 1.0
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 1.0
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 0.6
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 0.5
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 0.3
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 0.3
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

SERPIND1 is not prognostic in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 345.21
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 652.4
Number of samples 231
Samples
Sample Description pTPM
DO45137 38 years, male, NA, stage:1, alive, 1320 days 2097.7
DO45096 69 years, male, NA, stage:2, dead, 1290 days 2066.3
DO50807 67 years, male, NA, stage:1, alive, 540 days 1916.9
DO45219 78 years, male, NA, stage:2, alive, 1080 days 1706.2
DO48681 57 years, male, NA, stage:2, alive, 900 days 1688.5
DO45179 78 years, female, NA, stage:2, alive, 600 days 1593.7
DO23511 83 years, female, NA, stage:3, dead, 180 days 1517.1
DO45203 71 years, female, NA, stage:2, alive, 1170 days 1499.7
DO45187 32 years, female, NA, stage:1, alive, 1260 days 1489.7
DO23539 77 years, male, NA, stage:1, alive, 1110 days 1425.9
DO48701 78 years, male, NA, stage:2, alive, 780 days 1375.8
DO50820 77 years, female, NA, stage:3, alive, 510 days 1351.2
DO50789 73 years, female, NA, stage:2, alive, 570 days 1350.8
DO45129 61 years, male, NA, stage:3, alive, 1470 days 1324.7
DO45113 58 years, male, NA, stage:3, alive, 1560 days 1324.2
DO50808 68 years, male, NA, stage:2, alive, 570 days 1306.4
DO23550 69 years, male, NA, stage:1, alive, 990 days 1280.6
DO23521 63 years, male, NA, stage:3, alive, 1110 days 1268.1
DO45131 53 years, male, NA, stage:4, dead, 360 days 1248.9
DO45255 81 years, male, NA, stage:3, alive, 720 days 1245.5
DO23534 60 years, male, NA, stage:2, alive, 840 days 1222.0
DO23527 72 years, male, NA, stage:1, alive, 1050 days 1212.6
DO45199 86 years, female, NA, stage:2, alive, 1350 days 1208.4
DO45133 64 years, male, NA, stage:3, dead, 660 days 1146.7
DO23513 76 years, male, NA, stage:3, alive, 1200 days 1135.8
DO48751 68 years, male, NA, stage:2, dead, 480 days 1134.2
DO45115 81 years, male, NA, stage:2, alive, 840 days 1123.8
DO23538 67 years, male, NA, stage:2, alive, 450 days 1122.1
DO45207 68 years, male, NA, stage:1, alive, 1050 days 1121.7
DO48761 55 years, male, NA, stage:2, alive, 870 days 1116.3
DO45159 65 years, male, NA, stage:3, alive, 1470 days 1071.4
DO45183 72 years, female, NA, stage:2, dead, 570 days 1045.8
DO48706 72 years, male, NA, stage:2, alive, 870 days 1037.6
DO48760 70 years, female, NA, stage:2, alive, 690 days 1026.7
DO45155 69 years, male, NA, stage:2, alive, 2160 days 1011.9
DO50793 76 years, male, NA, stage:4, alive, 540 days 1009.2
DO48743 69 years, female, NA, stage:2, alive, 570 days 1008.3
DO48715 58 years, female, NA, stage:2, dead, 690 days 994.0
DO45239 42 years, male, NA, stage:2, alive, 870 days 993.1
DO48746 76 years, male, NA, stage:3, alive, 570 days 992.7
DO45247 31 years, female, NA, stage:2, alive, 210 days 990.3
DO48757 68 years, female, NA, stage:3, alive, 480 days 985.2
DO48725 66 years, male, NA, stage:1, alive, 780 days 966.7
DO48719 80 years, male, NA, stage:2, alive, 690 days 964.5
DO23531 78 years, female, NA, stage:3, alive, 900 days 956.3
DO23514 64 years, male, NA, stage:2, alive, 1290 days 955.1
DO23529 72 years, male, NA, stage:4, alive, 930 days 951.9
DO48727 81 years, female, NA, stage:2, dead, 390 days 949.9
DO45227 57 years, female, NA, stage:2, alive, 1020 days 936.6
DO45205 67 years, female, NA, stage:2, dead, 90 days 934.6
DO48695 77 years, male, NA, stage:2, alive, 720 days 930.1
DO45163 76 years, male, NA, stage:2, alive, 960 days 926.3
DO50787 63 years, male, NA, stage:3, alive, 480 days 904.0
DO45121 61 years, male, NA, stage:3, alive, 1530 days 896.0
DO50819 72 years, female, NA, stage:2, alive, 510 days 882.2
DO45093 71 years, male, NA, stage:2, dead, 720 days 877.7
DO45091 56 years, male, NA, stage:2, dead, 1320 days 873.0
DO48677 58 years, male, NA, stage:3, alive, 1140 days 861.2
DO45197 51 years, male, NA, stage:2, alive, 1170 days 854.8
DO227801 77 years, female, NA, stage:1, alive, 660 days 840.5
DO45217 69 years, female, NA, stage:3, dead, 270 days 839.3
DO50850 74 years, male, NA, stage:3, alive, 720 days 837.1
DO23552 80 years, female, NA, stage:1, alive, 810 days 829.2
DO50804 81 years, male, NA, stage:2, alive, 720 days 826.4
DO48723 73 years, male, NA, stage:1, alive, 600 days 824.5
DO48721 58 years, female, NA, stage:1, alive, 900 days 821.9
DO50855 47 years, male, NA, stage:2, alive, 570 days 819.7
DO45269 59 years, male, NA, stage:3, alive, 750 days 816.4
DO50802 49 years, male, NA, stage:2, alive, 930 days 811.7
DO45107 63 years, female, NA, stage:2, alive, 1710 days 810.0
DO45233 83 years, male, NA, stage:3, alive, 900 days 799.7
DO45213 58 years, male, NA, stage:1, alive, 1200 days 796.0
DO23528 45 years, female, NA, stage:2, alive, 1020 days 790.4
DO50818 65 years, male, NA, stage:2, alive, 510 days 789.7
DO45117 73 years, female, NA, stage:2, dead, 1110 days 788.7
DO23516 69 years, male, NA, stage:3, dead, 20 days 772.9
DO45201 49 years, male, NA, stage:1, alive, 900 days 770.6
DO23524 71 years, female, NA, stage:2, alive, 1050 days 770.1
DO45191 61 years, female, NA, stage:2, alive, 1200 days 769.2
DO45177 81 years, female, NA, stage:3, alive, 1260 days 766.0
DO23517 62 years, male, NA, stage:2, alive, 1200 days 761.2
DO50785 37 years, male, NA, stage:4, dead, 90 days 760.7
DO45261 74 years, male, NA, stage:3, alive, 990 days 755.3
DO48728 74 years, female, NA, stage:2, alive, 150 days 754.3
DO45223 67 years, male, NA, stage:4, alive, 1020 days 752.3
DO48742 76 years, male, NA, stage:2, alive, 600 days 752.1
DO45175 74 years, male, NA, stage:2, alive, 1140 days 747.9
DO50859 77 years, male, NA, stage:2, alive, 180 days 743.9
DO45173 63 years, male, NA, stage:3, alive, 1170 days 742.0
DO23515 71 years, male, NA, stage:2, alive, 1230 days 741.7
DO45161 74 years, male, NA, stage:2, dead, 540 days 740.7
DO45099 46 years, male, NA, stage:3, alive, 1590 days 738.9
DO50825 70 years, male, NA, stage:2, alive, 390 days 731.1
DO23541 65 years, male, NA, stage:2, alive, 930 days 728.3
DO45181 84 years, female, NA, stage:2, alive, 1200 days 727.4
DO50806 70 years, male, NA, stage:4, alive, 540 days 721.6
DO50822 66 years, male, NA, stage:2, alive, 510 days 714.8
DO23533 61 years, male, NA, stage:2, alive, 900 days 713.5
DO45171 56 years, male, NA, stage:3, alive, 600 days 706.5
DO45265 73 years, male, NA, stage:3, alive, 1020 days 699.3
DO48736 76 years, female, NA, stage:1, alive, 600 days 687.9
DO45135 77 years, male, NA, stage:1, alive, 1410 days 671.1
DO45125 58 years, male, NA, stage:3, alive, 1680 days 656.8
DO23548 78 years, female, NA, stage:1, alive, 840 days 653.8
DO50783 62 years, male, NA, stage:3, alive, 480 days 651.5
DO23536 56 years, male, NA, stage:2, alive, 930 days 648.5
DO45167 67 years, male, NA, stage:2, dead, 1440 days 647.6
DO50813 56 years, male, NA, stage:2, alive, 420 days 640.3
DO50774 68 years, female, NA, stage:2, alive, 720 days 636.5
DO45127 73 years, male, NA, stage:3, dead, 420 days 631.1
DO45229 74 years, male, NA, stage:1, alive, 990 days 626.7
DO48693 71 years, male, NA, stage:2, alive, 900 days 621.5
DO48674 80 years, male, NA, stage:2, alive, 1260 days 620.3
DO48712 50 years, male, NA, stage:2, alive, 810 days 611.5
DO23509 60 years, male, NA, stage:3, dead, 780 days 610.4
DO45243 74 years, female, NA, stage:3, alive, 930 days 605.0
DO45185 89 years, male, NA, stage:2, alive, 600 days 603.4
DO45094 76 years, male, NA, stage:3, alive, 1650 days 603.2
DO45241 49 years, male, NA, stage:1, alive, 1080 days 600.8
DO227643 79 years, male, NA, stage:2, alive, 1260 days 599.1
DO45092 62 years, male, NA, stage:4, dead, 1200 days 596.1
DO48730 73 years, female, NA, stage:2, alive, 630 days 593.8
DO48672 81 years, male, NA, stage:2, alive, 450 days 587.4
DO50778 60 years, male, NA, stage:4, alive, 630 days 584.5
DO23545 67 years, male, NA, stage:2, dead, 570 days 573.4
DO45281 83 years, male, NA, stage:4, alive, 750 days 570.6
DO45237 58 years, male, NA, stage:2, alive, 900 days 569.2
DO50798 77 years, male, NA, stage:3, dead, 30 days 569.1
DO48733 72 years, male, NA, stage:2, alive, 600 days 566.9
DO45123 78 years, female, NA, stage:2, dead, 570 days 561.5
DO48737 52 years, male, NA, stage:1, alive, 720 days 560.6
DO23525 71 years, male, NA, stage:4, alive, 1050 days 554.1
DO50776 75 years, male, NA, stage:1, alive, 690 days 552.2
DO45195 62 years, male, NA, stage:1, alive, 390 days 551.6
DO48759 73 years, male, NA, stage:3, alive, 720 days 551.1
DO50816 63 years, male, NA, stage:2, alive, 390 days 545.8
DO45193 68 years, female, NA, stage:4, dead, 120 days 540.1
DO48697 64 years, female, NA, stage:2, dead, 810 days 538.2
DO50844 75 years, male, NA, stage:4, alive, 300 days 536.2
DO50857 72 years, male, NA, stage:2, alive, 210 days 526.3
DO45221 75 years, female, NA, stage:4, dead, 390 days 524.4
DO45111 74 years, male, NA, stage:2, alive, 1590 days 522.5
DO45101 63 years, male, NA, stage:2, alive, 1680 days 522.4
DO23535 67 years, male, NA, stage:1, alive, 960 days 520.1
DO23544 67 years, male, NA, stage:2, alive, 960 days 515.9
DO50832 73 years, male, NA, stage:3, alive, 90 days 508.4
DO48704 68 years, female, NA, stage:3, alive, 750 days 508.1
DO45215 65 years, male, NA, stage:2, alive, 1170 days 502.6
DO45257 46 years, male, NA, stage:3, alive, 810 days 500.7
DO50840 49 years, male, NA, stage:2, alive, 330 days 495.4
DO48682 72 years, female, NA, stage:3, dead, 120 days 487.7
DO23542 66 years, male, NA, stage:3, alive, 960 days 481.2
DO45097 69 years, male, NA, stage:3, alive, 1620 days 479.8
DO23512 60 years, male, NA, stage:1, alive, 1260 days 476.3
DO50811 62 years, male, NA, stage:1, alive, 450 days 474.2
DO45143 69 years, male, NA, stage:3, alive, 1290 days 473.1
DO48741 64 years, male, NA, stage:3, alive, 240 days 470.4
DO50803 62 years, female, NA, stage:1, alive, 540 days 458.7
DO23526 66 years, male, NA, stage:3, alive, 1050 days 456.6
DO45157 62 years, male, NA, stage:2, alive, 1980 days 454.3
DO45141 73 years, male, NA, stage:2, alive, 1320 days 451.4
DO45119 74 years, male, NA, stage:3, dead, 510 days 447.1
DO45231 84 years, male, NA, stage:2, alive, 930 days 438.5
DO48679 72 years, male, NA, stage:2, alive, 1200 days 433.5
DO23540 73 years, male, NA, stage:1, alive, 750 days 431.8
DO23551 73 years, male, NA, stage:3, dead, 150 days 431.5
DO50845 72 years, male, NA, stage:3, alive, 210 days 431.2
DO45109 63 years, male, NA, stage:2, alive, 1590 days 414.4
DO23537 79 years, male, NA, stage:2, dead, 900 days 403.5
DO45189 85 years, female, NA, stage:2, alive, 1200 days 400.5
DO23508 79 years, female, NA, stage:2, alive, 390 days 397.4
DO48700 78 years, female, NA, stage:2, alive, 810 days 392.2
DO23543 63 years, male, NA, stage:2, alive, 1020 days 386.7
DO50809 56 years, male, NA, stage:3, dead, 720 days 385.9
DO23549 74 years, male, NA, stage:3, alive, 990 days 380.3
DO45225 69 years, male, NA, stage:1, alive, 1050 days 378.1
DO45105 61 years, male, NA, stage:1, alive, 1680 days 377.1
DO45153 77 years, female, NA, stage:2, alive, 1380 days 372.5
DO23532 71 years, female, NA, stage:1, alive, 960 days 368.3
DO50800 74 years, male, NA, stage:2, alive, 510 days 368.1
DO48716 71 years, male, NA, stage:2, alive, 720 days 365.8
DO23510 80 years, female, NA, stage:2, alive, 870 days 362.7
DO45169 74 years, male, NA, stage:3, alive, 1350 days 354.2
DO50839 47 years, female, NA, stage:3, alive, 330 days 349.0
DO45095 66 years, male, NA, stage:2, alive, 1620 days 341.4
DO50817 75 years, male, NA, stage:2, alive, 390 days 340.2
DO45253 50 years, male, NA, stage:2, alive, 870 days 335.0
DO45235 68 years, female, NA, stage:1, alive, 900 days 323.5
DO23518 67 years, male, NA, stage:2, alive, 1320 days 318.8
DO45165 75 years, male, NA, stage:2, alive, 690 days 317.3
DO45267 73 years, male, NA, stage:3, dead, 570 days 306.8
DO50814 83 years, male, NA, stage:3, alive, 420 days 305.2
DO50805 72 years, male, NA, stage:2, alive, 690 days 305.0
DO45263 67 years, male, NA, stage:3, dead, 270 days 304.2
DO48720 62 years, female, NA, stage:2, alive, 570 days 297.5
DO50799 66 years, female, NA, stage:2, alive, 540 days 264.8
DO45103 47 years, male, NA, stage:3, alive, 450 days 248.0
DO45209 70 years, male, NA, stage:4, alive, 1350 days 244.8
DO45259 65 years, male, NA, stage:3, alive, 330 days 219.1
DO50791 79 years, female, NA, stage:1, dead, 480 days 215.3
DO48717 54 years, male, NA, stage:4, dead, 180 days 207.1
DO23546 63 years, male, NA, stage:2, alive, 1050 days 206.4
DO45149 70 years, female, NA, stage:2, alive, 1260 days 180.5
DO48732 73 years, male, NA, stage:3, alive, 630 days 170.5
DO45139 63 years, male, NA, stage:3, alive, 1320 days 155.8
DO23530 53 years, male, NA, stage:4, dead, 180 days 145.9
DO45273 62 years, male, NA, stage:2, alive, 480 days 135.1
DO23519 65 years, male, NA, stage:3, alive, 630 days 96.8
DO50815 62 years, male, NA, stage:3, alive, 150 days 90.4
DO45251 57 years, female, NA, stage:2, alive, 900 days 70.9
DO23547 74 years, male, NA, stage:1, alive, 1020 days 66.2
DO45145 78 years, male, NA, stage:3, dead, 60 days 53.2
DO45275 65 years, male, NA, stage:3, dead, 10 days 50.2
DO48747 62 years, male, NA, stage:3, alive, 540 days 46.1
DO45249 57 years, male, NA, stage:1, alive, 630 days 42.2
DO50829 78 years, male, NA, stage:3, alive, 570 days 32.9
DO45301 56 years, male, NA, stage:2, dead, 1440 days 14.3
DO45287 74 years, male, NA, stage:1, alive, 390 days 10.0
DO45305 66 years, male, NA, stage:4, alive, 300 days 6.5
DO45279 67 years, male, NA, stage:3, alive, 1290 days 2.7
DO45283 60 years, male, NA, stage:3, alive, 510 days 2.6
DO45277 64 years, male, NA, stage:3, alive, 600 days 2.2
DO45307 54 years, female, NA, stage:4, dead, 240 days 1.8
DO45245 75 years, female, NA, stage:2, dead, 240 days 1.8
DO45303 62 years, female, NA, stage:3, alive, 990 days 1.5
DO45289 78 years, female, NA, stage:3, alive, 360 days 1.1
DO23523 52 years, male, NA, stage:3, alive, 1080 days 1.1
DO45299 70 years, female, NA, stage:1, alive, 1440 days 0.3
DO45285 59 years, male, NA, stage:3, alive, 480 days 0.2
DO45211 76 years, male, NA, stage:3, alive, 240 days 0.2
DO45297 61 years, female, NA, stage:4, dead, 1260 days 0.1
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
877 Tumor 1.8
863 Tumor 1.6
425 Tumor 1.4
921 Tumor 1.2
671 Tumor 1.2
517 Tumor 1.1
363 Tumor 1.1
1045 Tumor 1.0
713 Tumor 1.0
665 Tumor 1.0
463 Tumor 0.9
343 Tumor 0.9
445 Tumor 0.9
635 Tumor 0.9
777 Tumor 0.8
975 Tumor 0.8
224 Normal 0.8
223 Tumor 0.7
313 Tumor 0.7
471 Tumor 0.7
857 Tumor 0.7
192 Normal 0.6
743 Tumor 0.6
636 Normal 0.6
131 Tumor 0.6
387 Tumor 0.6
391 Tumor 0.6
983 Tumor 0.5
967 Tumor 0.5
817 Tumor 0.5
697 Tumor 0.5
815 Tumor 0.5
778 Normal 0.5
261 Tumor 0.4
695 Tumor 0.4
217 Tumor 0.4
964 Normal 0.4
113 Tumor 0.4
384 Normal 0.4
147 Tumor 0.4
124 Normal 0.4
813 Tumor 0.4
884 Normal 0.4
112 Tumor 0.4
328 Normal 0.4
221 Tumor 0.4
277 Tumor 0.4
257 Tumor 0.4
785 Tumor 0.3
1027 Tumor 0.3
125 Tumor 0.3
981 Tumor 0.3
137 Tumor 0.3
958 Normal 0.3
1046 Normal 0.3
515 Tumor 0.3
818 Normal 0.3
922 Normal 0.3
744 Normal 0.3
331 Tumor 0.3
727 Tumor 0.3
641 Tumor 0.3
396 Normal 0.3
938 Normal 0.3
142 Normal 0.3
672 Normal 0.3
433 Tumor 0.3
484 Normal 0.3
1028 Normal 0.3
666 Normal 0.3
615 Tumor 0.3
487 Tumor 0.3
375 Tumor 0.3
553 Tumor 0.2
421 Tumor 0.2
516 Normal 0.2
571 Tumor 0.2
314 Normal 0.2
428 Normal 0.2
443 Tumor 0.2
977 Tumor 0.2
924 Normal 0.2
715 Tumor 0.2
498 Normal 0.2
866 Normal 0.2
354 Normal 0.2
526 Normal 0.2
435 Tumor 0.2
1041 Tumor 0.2
878 Normal 0.2
474 Normal 0.2
444 Normal 0.2
745 Tumor 0.2
546 Normal 0.2
618 Normal 0.2
514 Normal 0.2
918 Normal 0.2
882 Normal 0.2
368 Normal 0.2
616 Normal 0.2
617 Tumor 0.2
365 Tumor 0.2
982 Normal 0.2
342 Normal 0.2
858 Normal 0.2
146 Normal 0.2
723 Tumor 0.2
227 Tumor 0.2
196 Normal 0.2
518 Normal 0.2
452 Normal 0.2
648 Normal 0.2
477 Tumor 0.2
472 Normal 0.2
1022 Normal 0.2
534 Normal 0.1
756 Normal 0.1
568 Normal 0.1
523 Tumor 0.1
737 Tumor 0.1
574 Normal 0.1
414 Normal 0.1
468 Normal 0.1
341 Tumor 0.1
746 Normal 0.1
488 Normal 0.1
432 Normal 0.1
135 Tumor 0.1
141 Tumor 0.1
525 Tumor 0.1
1015 Tumor 0.1
148 Normal 0.1
364 Normal 0.1
912 Normal 0.1
464 Normal 0.1
881 Tumor 0.1
1042 Normal 0.1
572 Normal 0.1
218 Normal 0.1
111 Normal 0.1
696 Normal 0.1
554 Normal 0.1
436 Normal 0.1
545 Tumor 0.1
465 Tumor 0.1
191 Tumor 0.1
564 Normal 0.1
714 Normal 0.1
742 Normal 0.1
162 Normal 0.1
424 Normal 0.1
864 Normal 0.1
284 Normal 0.1
232 Normal 0.1
426 Normal 0.1
1014 Normal 0.1
466 Normal 0.1
686 Normal 0.1
642 Normal 0.1
728 Normal 0.1
513 Tumor 0.1
327 Tumor 0.1
188 Normal 0.1
482 Normal 0.0
563 Tumor 0.0
462 Normal 0.0
138 Normal 0.0
963 Tumor 0.0
954 Normal 0.0
186 Normal 0.0
114 Normal 0.0
926 Normal 0.0
297 Tumor 0.0
132 Normal 0.0
1044 Normal 0.0
916 Normal 0.0
448 Normal 0.0
944 Normal 0.0
716 Normal 0.0
984 Normal 0.0
187 Tumor 0.0
1026 Normal 0.0
524 Normal 0.0
663 Tumor 0.0
786 Normal 0.0
497 Tumor 0.0
816 Normal 0.0
386 Normal 0.0
376 Normal 0.0
741 Tumor 0.0
824 Normal 0.0
388 Normal 0.0
862 Normal 0.0
976 Normal 0.0
956 Normal 0.0
558 Normal 0.0
851 Tumor 0.0
865 Tumor 0.0
446 Normal 0.0
952 Normal 0.0
126 Normal 0.0
1032 Normal 0.0
461 Tumor 0.0
868 Normal 0.0
298 Normal 0.0
883 Tumor 0.0
127 Tumor 0.0
258 Normal 0.0
494 Normal 0.0
874 Normal 0.0
738 Normal 0.0
968 Normal 0.0
123 Tumor 0.0
481 Tumor 0.0
1016 Normal 0.0
394 Normal 0.0
722 Normal 0.0
271 Tumor -0.1
362 Normal -0.1
128 Normal -0.1
628 Normal -0.1
171 Tumor -0.1
358 Normal -0.1
456 Normal -0.1
367 Tumor -0.1
431 Tumor -0.1
664 Normal -0.1
392 Normal -0.1
262 Normal -0.1
557 Tumor -0.1
724 Normal -0.1
355 Tumor -0.1
312 Normal -0.1
915 Tumor -0.1
647 Tumor -0.1
356 Normal -0.1
195 Tumor -0.1
478 Normal -0.1
911 Tumor -0.1
136 Normal -0.1
535 Tumor -0.1
852 Normal -0.1
483 Tumor -0.1
272 Normal -0.1
283 Tumor -0.1
332 Normal -0.1
455 Tumor -0.1
228 Normal -0.1
422 Normal -0.1
185 Tumor -0.1
222 Normal -0.1
278 Normal -0.1
937 Tumor -0.1
268 Normal -0.1
172 Normal -0.1
755 Tumor -0.1
451 Tumor -0.1
823 Tumor -0.1
538 Normal -0.1
145 Tumor -0.1
965 Tumor -0.1
212 Normal -0.2
491 Tumor -0.2
527 Tumor -0.2
914 Normal -0.2
214 Normal -0.2
662 Normal -0.2
925 Tumor -0.2
423 Tumor -0.2
814 Normal -0.2
1021 Tumor -0.2
395 Tumor -0.2
536 Normal -0.2
913 Tumor -0.2
492 Normal -0.2
416 Normal -0.2
917 Tumor -0.2
383 Tumor -0.2
161 Tumor -0.2
953 Tumor -0.2
412 Normal -0.2
361 Tumor -0.2
978 Normal -0.2
415 Tumor -0.2
286 Normal -0.2
1043 Tumor -0.2
951 Tumor -0.2
344 Normal -0.2
923 Tumor -0.2
352 Normal -0.2
698 Normal -0.2
231 Tumor -0.3
434 Normal -0.3
285 Tumor -0.3
267 Tumor -0.3
567 Tumor -0.3
966 Normal -0.3
467 Tumor -0.3
413 Tumor -0.3
366 Normal -0.3
528 Normal -0.3
943 Tumor -0.3
427 Tumor -0.3
957 Tumor -0.3
353 Tumor -0.3
627 Tumor -0.3
873 Tumor -0.3
473 Tumor -0.3
685 Tumor -0.4
357 Tumor -0.4
393 Tumor -0.4
311 Tumor -0.4
1025 Tumor -0.4
955 Tumor -0.4
385 Tumor -0.4
867 Tumor -0.4
351 Tumor -0.4
573 Tumor -0.5
447 Tumor -0.5
861 Tumor -0.5
661 Tumor -0.5
213 Tumor -0.5
721 Tumor -0.6
537 Tumor -0.7
493 Tumor -0.7
1031 Tumor -0.7
533 Tumor -0.7
411 Tumor -0.7
211 Tumor -1.0
1013 Tumor -1.0
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA055767

Antibody CAB008639
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Cholangiocarcinoma
Carcinoma, Hepatocellular, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org